Clinical Trial: Molecular Pathological Analysis of Biopsy and Autopsy Specimens from Patients Who Developed Adverse Events following COVID-19 Infection and/or COVID-19 Vaccination (Japan)

Tokyo, Feb. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060702) titled 'Molecular Pathological Analysis of Biopsy and Autopsy Specimens from Patients Who Developed Adverse Events following COVID-19 Infection and/or COVID-19 Vaccination' on Feb. 18.

Study Type: Observational

Primary Sponsor: Institute - Japanese Society for Vaccine-related Complications

Condition: Condition - Adverse events following COVID-19 infection and/or COVID-19 vaccination Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To elucidate the molecular pathogenesis by detecting residual vaccine-derived nucleic acids or proteins using histological and molecular biologi...